InMode Ltd. (INMD): Price and Financial Metrics
GET POWR RATINGS... FREE!
INMD POWR Grades
- INMD scores best on the Quality dimension, with a Quality rank ahead of 96.78% of US stocks.
- The strongest trend for INMD is in Quality, which has been heading down over the past 177 days.
- INMD ranks lowest in Stability; there it ranks in the 7th percentile.
INMD Stock Summary
- INMODE LTD's stock had its IPO on August 8, 2019, making it an older stock than just 17.01% of US equities in our set.
- The ratio of debt to operating expenses for INMODE LTD is higher than it is for about only 7.06% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.15 for INMODE LTD; that's greater than it is for merely 11.27% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to INMODE LTD are APYX, MLSS, HNST, THRN, and PLAG.
- Visit INMD's SEC page to see the company's official filings. To visit the company's web site, go to www.inmodemd.com.
INMD Valuation Summary
- INMD's price/sales ratio is 6.5; this is 217.07% higher than that of the median Healthcare stock.
- Over the past 42 months, INMD's price/earnings ratio has gone down 3.4.
Below are key valuation metrics over time for INMD.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| INMD | 2023-01-20 | 6.5 | 5.6 | 16.0 | 14.3 |
| INMD | 2023-01-19 | 6.4 | 5.5 | 15.7 | 14.1 |
| INMD | 2023-01-18 | 6.6 | 5.6 | 16.2 | 14.5 |
| INMD | 2023-01-17 | 6.7 | 5.7 | 16.5 | 14.8 |
| INMD | 2023-01-13 | 6.2 | 5.3 | 15.2 | 13.6 |
| INMD | 2023-01-12 | 6.3 | 5.3 | 15.3 | 13.7 |
INMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- INMD has a Quality Grade of A, ranking ahead of 95.1% of graded US stocks.
- INMD's asset turnover comes in at 0.881 -- ranking 27th of 186 Medical Equipment stocks.
- 500 - Internal server error
The table below shows INMD's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.881 | 0.853 | 0.578 |
| 2021-06-30 | 0.892 | 0.851 | 0.588 |
| 2021-03-31 | 0.808 | 0.850 | 0.517 |
| 2020-12-31 | 0.795 | 0.850 | 0.460 |
| 2020-09-30 | 0.741 | 0.852 | 0.383 |
| 2020-06-30 | 0.723 | 0.861 | 0.363 |
INMD Price Target
For more insight on analysts targets of INMD, see our INMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $123.80 | Average Broker Recommendation | 1.3 (Strong Buy) |
INMD Stock Price Chart Interactive Chart >
INMD Price/Volume Stats
| Current price | $35.48 | 52-week high | $54.68 |
| Prev. close | $34.92 | 52-week low | $20.60 |
| Day low | $34.56 | Volume | 782,700 |
| Day high | $35.84 | Avg. volume | 1,720,911 |
| 50-day MA | $35.80 | Dividend yield | N/A |
| 200-day MA | $30.93 | Market Cap | 2.95B |
InMode Ltd. (INMD) Company Bio
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.
Latest INMD News From Around the Web
Below are the latest news stories about INMODE LTD that investors may wish to consider to help them evaluate INMD as an investment opportunity.
With EPS Growth And More, InMode (NASDAQ:INMD) Makes An Interesting CaseIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story... |
InMode Stock Glowing Again As Cosmetic Surgery Market RecoversInMode stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. |
2 Promising New Growth Stocks to Watch in 2023It's important to remember, though, that today's economic troubles and stock market downturn are temporary. Certain growth stocks may suffer in this sort of context. One is a medical technology company that's set to report record earnings. |
3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses. |
Got $3,000? 3 Growth Stocks to Double Up On Right NowWith these growth stocks down between 25% and 38% over the last year, it may be time to add to them as they widen their moats. |
INMD Price Returns
| 1-mo | -0.62% |
| 3-mo | 3.38% |
| 6-mo | 4.51% |
| 1-year | -20.59% |
| 3-year | 52.44% |
| 5-year | N/A |
| YTD | -0.62% |
| 2022 | -49.42% |
| 2021 | 197.30% |
| 2020 | 21.12% |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...